A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...
News Medical on MSN6d
Gut-derived sugars: A potential game-changer for weight management and diabetesGut bacteria-produced exopolysaccharides (EPS) help regulate metabolism by modulating gut microbiota, promoting SCFA ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
Emerging antidiabetic drugs sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RAs), and dipeptidyl peptidase-4 inhibitors (DPP-4i) have demonstrated ...
Intriguingly, several overlaps have been shown between the two disorders, e.g., inflammatory activation, oxidative stress, glucose and insulin pathways, wingless-INT/mammalian target of rapamycin (Wnt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback